GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Net Debt Paydown Yield %

Targeted Medical Pharma (Targeted Medical Pharma) Net Debt Paydown Yield % : 0.00% (As of May. 18, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Net Debt Paydown Yield %?

Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt. As of today, Targeted Medical Pharma's Net Debt Paydown Yield % was 0.00%.


Targeted Medical Pharma Net Debt Paydown Yield % Historical Data

The historical data trend for Targeted Medical Pharma's Net Debt Paydown Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Targeted Medical Pharma Net Debt Paydown Yield % Chart

Targeted Medical Pharma Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Net Debt Paydown Yield %
Get a 7-Day Free Trial - - - - -

Targeted Medical Pharma Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Net Debt Paydown Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Targeted Medical Pharma's Net Debt Paydown Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Targeted Medical Pharma's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Targeted Medical Pharma's Net Debt Paydown Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Targeted Medical Pharma's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where Targeted Medical Pharma's Net Debt Paydown Yield % falls into.



Targeted Medical Pharma Net Debt Paydown Yield % Calculation

Targeted Medical Pharma's Net Debt Paydown Yield % for the quarter that ended in Dec. 2015 is calculated as:

Net Debt Paydown Yield %
=( TTM Average Debt   (1-Year Ago))-TTM Average Debt )/Market Cap
=( 4-5.29 )/0.535376
=-239.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.


Targeted Medical Pharma  (OTCPK:TRGM) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.


Targeted Medical Pharma Net Debt Paydown Yield % Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Net Debt Paydown Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Traded in Other Exchanges
N/A
Address
2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077
Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.
Executives
William B. Horne officer: Chief Financial Officer C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald director C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph officer: See Remarks C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour director, 10 percent owner, officer: Former President C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher director 12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke officer: Chief Financial Officer C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc 10 percent owner, other: Former 10% Owner 269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel director, officer: Vice President 16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma (Targeted Medical Pharma) Headlines

No Headlines